Active — Not RecruitingPhase 4

Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers

Canada155 participantsStarted 2022-11-10

Plain-language summary

Local anesthetic resistance is commonly reported by patients with EDS. However, there are no objective data on the occurrence of local anesthetic resistance in EDS patients and in healthy volunteers. The investigators propose to collect such objective data on the frequency of drug resistance and whether any problems with local anesthesia are due to initial ineffectiveness or due to its effects dissipating too soon.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * EDS patients, clinically diagnosed hypermobile EDS based on 2017 criteria * EDS patients with genetically proven non-hypermobile EDS * Healthy participants, no EDS * Able and willing to provide informed consent Exclusion Criteria: * Known allergy to Lidocaine * Unable to provide informed consent

What they're measuring

Delta Pain Scores Lidocaine at 5 min [ Time Frame: 5 minutes post-injection ]

Timeframe: 5 minutes post-injection

Trial details

NCT IDNCT05603741

SponsorUniversity of Calgary

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-01

View on ClinicalTrials.gov More Ehlers-Danlos Syndrome trials